Development of a hamster model of spontaneous hypertriglyceridemia in diabetes

Abstract

Hypertriglyceridemia (HTG) often accompanies diabetes and is considered a risk factor for diabetic vascular complications. However, inducing diabetic HTG typically requires high-fat diets in certain animal models. Leveraging our newly developed LDL receptor knockout hamster model, which exhibits features akin to human lipid metabolism, we sought to determine whether these animals would develop HTG without dietary manipulations in diabetes. Diabetes was induced via intraperitoneal injection of STZ in wild type and heterozygous LDL receptor deficient hamsters. Blood glucose, triglyceride, and cholesterol were measured over 60 days. Plasma TG clearance was determined via olive oil gavage. The effect of insulin on diabetic HTG was assessed on Day 60 post-diabetes induction. Blood glucose increased over threefold, while plasma insulin decreased to 30% of controls after STZ injection in both wild type and heterozygous hamsters by Day 7, remaining stable for 60 days. Plasma TG in wild-type hamsters remained unchanged at Day 7 post-STZ injection but increased slightly thereafter. Conversely, heterozygous hamsters exhibited severe HTG by Day 7 until the end of the study. Olive oil gavage revealed much slower plasma triglyceride clearance in heterozygous hamsters compared to WT animals, despite significantly reduced lipoprotein lipase activity in post-heparin plasma in both animals. Hyperglycemia and HTG in heterozygous hamsters were reversed to pre-diabetic levels following intraperitoneal insulin administration. In conclusion, severe HTG in diabetic heterozygous LDL receptor deficient hamsters developed spontaneously and was insulin-dependent. Thus, this hamster model holds promise for effectively studying the complications associated with human diabetic HTG.

Keywords

diabetes / hamster / hypertriglyceridemia / LDL receptors

References

[1] Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570-2578.

[2] Kurooka N, Eguchi J, Wada JJ. Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes. Diabetes Investig. 2023;14(10):1148-1156.

[3] Goldberg IJ, Dansky HM. Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol. 2006;26(8):1693-1701.

[4] Shen X, Bornfeldt KE. Mouse models for studies of cardiovascular complications of type 1 diabetes. Ann N Y Acad Sci. 2007;1103:202-217.

[5] Reaven P, Merat S, Casanada F, Sutphin M, Palinski W. Effect of streptozotocin induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesion, and extent of atherosclerosis in LDL-receptor-deficient mice. Arterioscler Thromb Vasc Biol. 1997;17:2250-2256.

[6] Getz GS, Reardon CA. Use of mouse models in atherosclerosis research. Methods Mol Biol. 2015;1339:1-16.

[7] Dillard A, Matthan NR. Lichtenstein AH use of hamster as a model to study diet-induced atherosclerosis. Nutr Metab (Lond). 2010;7:89.

[8] Guo X, Gao M, Wang Y, et al. LDL receptor gene-ablated hamsters: a rodent model of familial hypercholesterolemia with dominant inheritance and diet-induced coronary atherosclerosis. EBioMedicine. 2018;27:214-224.

[9] Di Filippo M, Marçais C, Charrière S, et al. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. PLoS One. 2014;9(6):e99721.

[10] Uehara K, Santoleri D, Whitlock AEG, Titchenell PM. Insulin regulation of hepatic lipid homeostasis. Compr Physiol. 2023;13(3):4785-4809.

[11] Dallinga-Thie GM, Franssen R, Mooij HL, et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis. 2010;211(2):1-8.

[12] Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106(4):453-458.

[13] Goldberg IJ, Eckel RH, Abumrad NA. Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways. J Lipid Res. 2009;50:S86-S90.

[14] Gao S, He L. Ding Y and Liu G*: mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion. BBRC. 2010;398(4):619-626.

[15] Wang J, He K, Yang C, Lin X, Zhang X, Wang Y. Liu G* and Xian X: dietary cholesterol is highly associated with severity of hyperlipidemia and atherosclerotic lesions in heterozygous LDLR-deficient hamsters. Int J Mol Sci. 2019;20(14):3515.

[16] Paquette M, Bernard S, Ruel I, Blank DW, Genest J, Baass A. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia. J Clin Lipidol. 2018;S1933-2874(18):30406-30409.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.